Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06864403

Title field or adapter rule

{'original_value': 'Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.005898+00:00

Published At

2026-10-29T00:00:00+00:00

Record Updated At

2026-10-29

Source Retrieved At

2026-10-31T22:18:54.666292+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pouchitis", "Pouches, Ileoanal", "Pouch, Ileal"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06864403"

protocolSection.identificationModule.officialTitle

"Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pouchitis (protocolSection.conditionsModule.conditions)
• Pouches, Ileoanal (protocolSection.conditionsModule.conditions)
• Pouch, Ileal (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['All patients'], 'description': '300 mg mirikizumab at Weeks 0, 4, and 8', 'name': 'Mirikizumab - Intravenous (IV)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['All patients'], 'description': 'Pre-filled syringes administered at Weeks 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, and 52.', 'name': 'Mirikizumab - Subcutaneous (SC)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Mirikizumab - Intravenous (IV) (protocolSection.armsInterventionsModule.interventions[].name)
• Mirikizumab - Subcutaneous (SC) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.